Edwin M. Posadas

A phase 2 study of KX2-391, an oral inhibitor of Src kinase and tubulin polymerization, in men with bone-metastatic castration-resistant prostate cancer

Steve Y. Cho, M. Harrison, G. Wilding, 2013, Cancer Chemotherapy and Pharmacology.

ONCONEPHROLOGY: Targeted therapies for renal cell carcinoma

R. Figlin, E. Posadas, S. Limvorasak, 2017 .